Unlocking the promise of innate biology through the HLA-G/ILT2/ILT4 pathway
Inhibitory immune pathways have gained considerable attention following the clinical success of immune checkpoint inhibitors in cancer. While much focus has been placed on classical checkpoints such as programmed cell death protein-1 (PD-1)/programmed…